Bovie Medical Corporation, a medical device company, develops, manufactures, and markets electrosurgical devices and technologies, and related medical products used in doctor's offices, surgery centers, and hospitals worldwide. The company provides electrosurgical products, including desiccators, generators, electrodes, electrosurgical pencils, and various ancillary disposable products used during surgical procedures in gynecology, urology, plastic surgery, dermatology, veterinary, and other surgical markets for the cutting and coagulation of tissue. It also offers electrosurgical disposables comprising Resistick II, a proprietary coating applied to stainless steel that resist eschar during surgery; and disposable laparoscopic electrodes for use by physicians in the areas of gynecology, general surgery, and urology. In addition, the company provides battery operated cauteries for precise hemostasis in ophthalmology; nerve locator stimulator primarily used for identifying motor nerves in hand and facial reconstructive surgery; penlights for use in offices; and specialty lighting instruments for use in ophthalmology, as well as distributes specialty lighting instruments for general surgery, hip replacement surgery, and endotracheal tubes placement. Further, it develops J-Plasma, a patented helium-based plasma surgical product, as well as designs, develops, and manufactures electrosurgical equipment by producing equipment for medical device manufacturers through original equipment manufacturing agreements. Bovie Medical Corporation markets its products to distributors under own brands, such as Bovie, IDS, and DERM, as well as under a private label. The company was formerly known as An-Con Genetics Inc. and changed its name to Bovie Medical Corporation in October 1998. Bovie Medical Corporation was incorporated in 1982 and is based in Clearwater, Florida.
Industry, Sector and Symbol
Stock Exchange NYSEAMERICAN
Industry Medical Instruments & Supplies
Sub-IndustryN/A
SectorMedical
SymbolNYSEAMERICAN:BVX
CUSIPN/A
Phone+1-727-3842323
Debt
Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A
Price-To-Earnings
Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A
Sales & Book Value
Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / CashN/A
Book ValueN/A
Price / BookN/A
Profitability
EPS (Most Recent Fiscal Year)N/A
Net IncomeN/A
Net Margins-13.32%
Return on Equity-21.67%
Return on Assets-15.79%
Miscellaneous
EmployeesN/A
Outstanding Shares33,200,000
Market Cap$76.91 million
Bovie Medical (NYSEAMERICAN:BVX) Frequently Asked Questions
What is Bovie Medical's stock symbol?
Bovie Medical trades on the New York Stock Exchange (NYSE)AMERICAN under the ticker symbol "BVX."
How were Bovie Medical's earnings last quarter?
Bovie Medical Co. (NYSEAMERICAN:BVX) posted its quarterly earnings data on Wednesday, August, 1st. The medical device company reported ($0.01) earnings per share (EPS) for the quarter, meeting the Zacks' consensus estimate of ($0.01). The medical device company had revenue of $11.50 million for the quarter, compared to the consensus estimate of $11.38 million. Bovie Medical had a negative net margin of 13.32% and a negative return on equity of 21.67%. The firm's revenue for the quarter was up 17.3% compared to the same quarter last year. View Bovie Medical's Earnings History.
When is Bovie Medical's next earnings date?
What price target have analysts set for BVX?
2 analysts have issued 12 month price targets for Bovie Medical's shares. Their forecasts range from $8.50 to $11.00. On average, they anticipate Bovie Medical's share price to reach $9.75 in the next twelve months. This suggests a possible upside of 32.7% from the stock's current price. View Analyst Price Targets for Bovie Medical.
What is the consensus analysts' recommendation for Bovie Medical?
2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Bovie Medical in the last year. There are currently 2 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Bovie Medical.
Are investors shorting Bovie Medical?
Bovie Medical saw a decrease in short interest during the month of August. As of August 15th, there was short interest totalling 42,658 shares, a decrease of 39.4% from the July 31st total of 70,444 shares. Based on an average daily trading volume, of 161,239 shares, the short-interest ratio is currently 0.3 days. Approximately 0.1% of the company's shares are short sold. View Bovie Medical's Current Options Chain.
Who are some of Bovie Medical's key competitors?
Some companies that are related to Bovie Medical include CRH Medical (CRH), CRH Medical (CRHM), Tristel (TSTL), TSO3 (TOS), Clover (CLV), InfuSystem (INFU), Retractable Technologies (RVP), Milestone Scientific (MLSS), IsoRay (ISR), Akers Biosciences (AKR), Daxor (DXR), Omega Diagnostics Group (ODX), Relevium Technologies (RLV), Vigil Health Solutions (VGL) and Iris BioTechnologies (IRSB).
Who are Bovie Medical's key executives?
Bovie Medical's management team includes the folowing people:
- Mr. Charles D. Goodwin II, CEO & Director (Age 52)
- Mr. J. Robert Saron, Pres, Chief Sales & Marketing Officer and Director (Age 65)
- Mr. Jay D. Ewers, CFO, Treasurer & Sec. (Age 57)
- Mr. Moshe Citronowicz, Sr. VP (Age 65)
- Mr. Jeffrey Rencher, VP of Sales & Marketing - Surgical Products (Age 51)
Has Bovie Medical been receiving favorable news coverage?
Media stories about BVX stock have trended somewhat positive recently, Accern Sentiment reports. The research firm rates the sentiment of media coverage by reviewing more than twenty million news and blog sources in real-time. Accern ranks coverage of public companies on a scale of -1 to 1, with scores nearest to one being the most favorable. Bovie Medical earned a coverage optimism score of 0.18 on Accern's scale. They also gave news stories about the medical device company an impact score of 46.57 out of 100, meaning that recent media coverage is somewhat unlikely to have an impact on the company's share price in the immediate future. View Recent Headlines for Bovie Medical.
Who are Bovie Medical's major shareholders?
Bovie Medical's stock is owned by a number of of retail and institutional investors. Top institutional investors include RTW Investments LP (6.27%), Royce & Associates LP (2.14%), Cortina Asset Management LLC (1.98%), Perkins Capital Management Inc. (1.21%), Cowen Prime Services LLC (1.05%) and ProVise Management Group LLC (1.00%). View Institutional Ownership Trends for Bovie Medical.
Which major investors are selling Bovie Medical stock?
Which major investors are buying Bovie Medical stock?
BVX stock was acquired by a variety of institutional investors in the last quarter, including ProVise Management Group LLC, Essex Investment Management Co. LLC, RTW Investments LP, Perkins Capital Management Inc., Boston Partners, Russell Investments Group Ltd., Raymond James Financial Services Advisors Inc. and Cortina Asset Management LLC. View Insider Buying and Selling for Bovie Medical.
How do I buy shares of Bovie Medical?
Shares of BVX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Bovie Medical's stock price today?
One share of BVX stock can currently be purchased for approximately $7.35.
How big of a company is Bovie Medical?
Bovie Medical has a market capitalization of $76.91 million.
How can I contact Bovie Medical?
Bovie Medical's mailing address is 4 Manhattanville Rd Ste 106, PURCHASE, NY 10577-2119, United States. The medical device company can be reached via phone at +1-727-3842323.
MarketBeat Community Rating for Bovie Medical (NYSEAMERICAN BVX)
MarketBeat's community ratings are surveys of what our community members think about Bovie Medical and other stocks. Vote "Outperform" if you believe BVX will outperform the S&P 500 over the long term. Vote "Underperform" if you believe BVX will underperform the S&P 500 over the long term. You may vote once every thirty days.
